Everlinq Reports Successful New Approach to Vascular Access

The everlinQ^TM System forms an HD access with radiofrequency energy at sites not traditionally used by surgeons. The system has CE Mark approval, but is not yet available in the U.S.

Read the full article » | Posted 12-10-2015

Related Articles

• VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
• Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
• eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
• The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025